The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and molecular determinants of treatment benefit with phase I trials in patients (pts) with advanced pancreatic cancer (PC).
 
Helena Verdaguer
No Relationships to Disclose
 
Tamara Sauri
No Relationships to Disclose
 
Jorge Zeron-Medina
No Relationships to Disclose
 
Guillermo Villacampa
No Relationships to Disclose
 
Jaume Capdevila
No Relationships to Disclose
 
Elena Elez
No Relationships to Disclose
 
Maria Alsina
No Relationships to Disclose
 
Guillem Argiles
No Relationships to Disclose
 
Cinta Hierro
No Relationships to Disclose
 
Julieta Grasselli
No Relationships to Disclose
 
Ignacio Matos
No Relationships to Disclose
 
Jordi Rodón
No Relationships to Disclose
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Celgene; Chugai Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche; Sanofi; Symphony Evolution; Taiho Pharmaceutical; Takeda
 
Rodrigo Dienstmann
Consulting or Advisory Role - Roche/Genentech
Research Funding - Merck
 
Enrique Sanz-Garcia
No Relationships to Disclose
 
Teresa Mercade Macarulla
No Relationships to Disclose